17 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Initiative (PAMI) - Opioid ... Dosing #Management ... #Pain #Pharmacology ... #Opioid #Opiate ... #Table #PAMI
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... For Adult and pediatric ... Then using Table ... #Pharmacology #Pain ... #Opiate #Opioid
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Initiative (PAMI) - Non-Opioid ... Dosing #Management ... #Pain #Pharmacology ... Medications #Doses #Dosing ... #Table #PAMI
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
Hospital Quick Start Algorithm ... that is safe and ... If patient is stable ... Buprenorphine Dosing ... chronic pain split dosing
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... inactivates GLP-1 and ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
: Weight-Based Dosing ... #TDD #Insulin #dosing ... Weight #Based #pharmacology ... #endocrinology ... #diabetes #DM2
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
severe bleeding and ... #management #algorithm ... #pharmacology # ... #medications #table ... hematology #warfarin #dosing
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
dose of insulin and ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table ... #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Renal Dosing ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes #DM2 ... #Endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Ozempic), or daily tablet ... Receptor #Agonists #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology